News & Updates

Thyroid hormones help predict cardiogenic shock risk in STEMI patients post-PCI

13 Mar 2022

Free triiodothyronine (FT3) and free thyroxine (FT4) independently predict in-hospital cardiogenic shock (CS) incidence among patients with ST-segment elevation myocardial infarction (STEMI) treated with percutaneous coronary intervention (PCI), reports a recent study.

Thyroid hormones help predict cardiogenic shock risk in STEMI patients post-PCI

13 Mar 2022

Empagliflozin lowers blood pressure in T2D

12 Mar 2022

Among hypertensives with type 2 diabetes (T2D), treatment with the sodium-glucose cotransporter 2 inhibitor empagliflozin produces clinically meaningful reductions in blood pressure, reports a recent study.

Empagliflozin lowers blood pressure in T2D

12 Mar 2022

Rivaroxaban preserves renal function better than warfarin in NVAF patients

11 Mar 2022

In treating nonvalvular atrial fibrillation (NVAF) patients, rivaroxaban carries a lower risk of renal decline than warfarin, a recent study has found.

Rivaroxaban preserves renal function better than warfarin in NVAF patients

11 Mar 2022

Magnesium supplementation confers no cardiovascular benefit

10 Mar 2022

Supplementation with oral magnesium for 24 weeks hardly produces any change in arterial stiffness or blood pressure (BP), as do magnesium oxide and magnesium sulphate, as shown in a study.

Magnesium supplementation confers no cardiovascular benefit

10 Mar 2022

Prostate cancer ADT linked to worsening metabolic profile

10 Mar 2022 by

Chinese patients receiving androgen deprivation therapy (ADT) for prostate cancer are exposed to increased risk of new-onset diabetes mellitus (DM), hyperlipidaemia and hypertension (HTN), as well as a higher likelihood of step-up pharmacotherapy for these pre-existing conditions, according to a prospective multicentre cohort study by the Chinese University of Hong Kong (CUHK) and Tuen Mun Hospital.

Prostate cancer ADT linked to worsening metabolic profile

10 Mar 2022

Novel filter device safe to use in patients undergoing TAVI

09 Mar 2022 by

A novel dual-filter device called the SENTINEL cerebral protection system (CPS) has been safely deployed in 95 percent of patients undergoing transcatheter aortic valve implantation (TAVI) with 100-percent procedural success, according to a Singapore study. No filter-related complications, stroke, or mortality has occurred at 30 days.

Novel filter device safe to use in patients undergoing TAVI

09 Mar 2022

Sedentary behaviour contributes to increased atrial fibrillation risk in older women

09 Mar 2022

Longer total sitting time and prolonged sedentary bouts put women at risk of developing atrial fibrillation, a study has found.

Sedentary behaviour contributes to increased atrial fibrillation risk in older women

09 Mar 2022

Significant BP elevation predicts response to VEGF inhibitors

08 Mar 2022

A significant increase in blood pressure (BP) appears predictive of therapeutic response to vascular endothelial growth factor (VEGF) inhibitors but does not limit treatment duration even in patients with severe elevations, suggests a study.

Significant BP elevation predicts response to VEGF inhibitors

08 Mar 2022

Plasma bile acid levels linked to cardiometabolic risk factors in young adults

08 Mar 2022 by

Plasma levels of bile acids (BA) appear to be dependent on sex and correlate with cardiometabolic and inflammatory risk factors in young and relatively healthy adults, according to a study.

Plasma bile acid levels linked to cardiometabolic risk factors in young adults

08 Mar 2022

Severe hypoglycaemia raises risk of heart failure in adults with T2D

08 Mar 2022

Severe hypoglycaemia may contribute to a higher risk of incident heart failure (HF) among adults with type 2 diabetes (T2D), reports a study.

Severe hypoglycaemia raises risk of heart failure in adults with T2D

08 Mar 2022

News & Updates

Filter by Specialty:

Specialty:

Thyroid hormones help predict cardiogenic shock risk in STEMI patients post-PCI

Thyroid hormones help predict cardiogenic shock risk in STEMI patients post-PCI

Empagliflozin lowers blood pressure in T2D

Empagliflozin lowers blood pressure in T2D

Rivaroxaban preserves renal function better than warfarin in NVAF patients

Rivaroxaban preserves renal function better than warfarin in NVAF patients

Magnesium supplementation confers no cardiovascular benefit

Magnesium supplementation confers no cardiovascular benefit

Prostate cancer ADT linked to worsening metabolic profile

Prostate cancer ADT linked to worsening metabolic profile

Novel filter device safe to use in patients undergoing TAVI

Novel filter device safe to use in patients undergoing TAVI

Sedentary behaviour contributes to increased atrial fibrillation risk in older women

Sedentary behaviour contributes to increased atrial fibrillation risk in older women

Significant BP elevation predicts response to VEGF inhibitors

Significant BP elevation predicts response to VEGF inhibitors

Plasma bile acid levels linked to cardiometabolic risk factors in young adults

Plasma bile acid levels linked to cardiometabolic risk factors in young adults

Severe hypoglycaemia raises risk of heart failure in adults with T2D

Severe hypoglycaemia raises risk of heart failure in adults with T2D